In December 2020, The FDA was called out for NOT testing for “microvascular injury to the brain, heart, liver, and kidneys” in the safety trials for the Covid-19 vaccines in a letter written by Patrick Whelan MD PhD, UCLA Pediatric Rheumatology (See below, download, copy and share).
Whelan warned the FDA of the danger of injecting humans with a spike protein producing biochemical drug. The risk to children, he concluded, was of particular concern.
The safety trials for these biochemical agents, were not safety trials at all. They were a cover. Millions have been illegally pressured, and coerced into taking this experimental agent in violation of international law. Thousands have died, others are suffering from terrible physical and neurological injury for which they are denied any assistance from the drug companies or the government, or even their places of employment.
8 December 2020
U.S. Food and Drug Administration
Vaccines and Related Biological Products Advisory Committee
RE:Notice of Meeting; Establishment of a Public Docket; Request for Comments related to consideration of vaccines against SARS-CoV-2
I am a pediatric specialist caring for children with the multisystem inflammatory syndrome (MIS-C). I am concerned about the possibility that the new vaccines aimed at creating immunity against the SARS-CoV-2 spike protein (including the mRNA vaccines of Moderna and Pfizer) have the potential to cause microvascular injury to the brain, heart, liver, and kidneys in a way that is not currently being assessed in safety trials of these potential drugs. […]
The Pfizer/BioNTech vaccine (BNT162b2) is composed of an mRNA that produces a membrane-anchored full-length spike protein. The mouse studies suggest that an untruncated form of the S1 protein like this may cause a microvasculopathy in tissues that express much ACE2 receptor. […]
… it appears that the viral spike protein that is the target of the major SARS-CoV-2 vaccines is also one of the key agents causing the damage to distant organs that may include the brain, heart, lung, and kidney. Before any of these vaccines are approved for widespread use in humans, it is important to assess in vaccinated subjects the effects of vaccination on the heart (perhaps using cardiac MRI, as Puntmannet al.did). Vaccinated patients could also be tested for distant tissue damage in deltoid area skin biopsies, as employed by Magro et al .As important as it is to quickly arrest the spread of the virus by immunizing the population, it would be vastly worse if hundreds of millions of people were to suffer long-lasting or even permanent damage to their brain or heart microvasculature as a result of failing to appreciate in the short-term an unintended effect of full-length spike protein-based vaccines on these other organs…
Particular caution will be required with regard to the potential widespread vaccination of children before there are any real data on the safety or effectiveness of these vaccines in pediatric trials that are only now beginning.
Patrick Whelan MD PhD
UCLA Pediatric Rheumatology
Los Angeles CA 90095
Read the letter in full here: